Oncology research and personalized cancer therapies will (and do) benefit greatly from the use of biomarkers. By illuminating genetic profiles and molecular pathways, biomarkers and biomarker signatures offer hope for truly personalized medicine in a field where the disease is extremely complex. Combinations of biomarkers may be used to direct therapy and monitor disease progression. A featured article in this week’s Gen magazine discusses these topics in more detail.
